Literature DB >> 23011520

Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum.

Ai Maeda1, Masao Nakata, Kouichiro Yasuda, Takuro Yukawa, Shinsuke Saisho, Riki Okita, Yuji Hirami, Katsuhiko Shimizu.   

Abstract

Unknown primary large cell neuroendocrine carcinoma (LCNEC) in the mediastinum is extremely rare. In this report, we present a case of a 53-year-old man with superior vena cava (SVC) syndrome who developed LCNEC in the middle mediastinum. His chief complaint was facial edema. Chest X-ray revealed an abnormal shadow in the right upper mediastinum. Computed tomography (CT) scan of the chest revealed a 67-mm mass in the middle mediastinum. Tumor invasion caused constriction of the SVC. The patient underwent induction chemoradiotherapy with vinorelbin and cisplatin and concurrent radiation therapy. After induction therapy, the tumor size decreased remarkably and was resected completely. The pathological diagnosis was LCNEC.

Entities:  

Mesh:

Year:  2012        PMID: 23011520     DOI: 10.1007/s11748-012-0157-5

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  11 in total

1.  Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Yasumitsu Moriya; Yuichi Takiguchi; Yasuo Sekine; Kiyoshi Shibuya; Toshihiko Iizasa; Hideki Kimura; Yukio Nakatani; Takehiko Fujisawa
Journal:  Ann Thorac Surg       Date:  2006-11       Impact factor: 4.330

2.  [Aggressively metastatic neuroendocrine carcinoma in the middle mediastinum].

Authors:  A Natsuhara; Y Iwasaki; T Minagawa; Y Takemura; M Nakanisi; K Nagata; H Harada; Y Kubota; I Yokomura; M Nakagawa
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2001-09

3.  Neuroendocrine neoplasms of the lung: a prognostic spectrum.

Authors:  Hisao Asamura; Toru Kameya; Yoshihiro Matsuno; Masayuki Noguchi; Hirohito Tada; Yuichi Ishikawa; Tomoyuki Yokose; Shi-Xu Jiang; Takeshi Inoue; Ken Nakagawa; Kinuko Tajima; Kanji Nagai
Journal:  J Clin Oncol       Date:  2006-01-01       Impact factor: 44.544

4.  Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung.

Authors:  Giulio Rossi; Alberto Cavazza; Alessandro Marchioni; Lucia Longo; Mario Migaldi; Giuliana Sartori; Nazzarena Bigiani; Laura Schirosi; Christian Casali; Uliano Morandi; Nicola Facciolongo; Antonio Maiorana; Mario Bavieri; Leonardo M Fabbri; Elisabeth Brambilla
Journal:  J Clin Oncol       Date:  2005-12-01       Impact factor: 44.544

5.  Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.

Authors:  W D Travis; R I Linnoila; M G Tsokos; C L Hitchcock; G B Cutler; L Nieman; G Chrousos; H Pass; J Doppman
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

6.  Fast-growing large cell neuroendocrine carcinoma of mediastinum.

Authors:  Olga Lukina; Stanislav Gorbunkov; Ivetta Dvorakovskaja; Vladimir Varlamov; Andrey Akopov
Journal:  Ann Thorac Surg       Date:  2011-05       Impact factor: 4.330

7.  Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.

Authors:  Hisashi Saji; Masahiro Tsuboi; Jun Matsubayashi; Kuniharu Miyajima; Yoshihisa Shimada; Kentaro Imai; Yasubumi Kato; Jitsuo Usuda; Naohiro Kajiwara; Osamu Uchida; Tatsuo Ohira; Takashi Hirano; Kiyoshi Mukai; Harubumi Kato; Norihiko Ikeda
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

8.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.

Authors:  W D Travis; W Rush; D B Flieder; R Falk; M V Fleming; A A Gal; M N Koss
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

9.  Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.

Authors:  Akira Iyoda; Kenzo Hiroshima; Yasumitsu Moriya; Yasuo Iwadate; Yuichi Takiguchi; Takashi Uno; Yukio Nakatani; Ichiro Yoshino
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03-26       Impact factor: 5.209

10.  Large cell neuroendocrine carcinoma of the mediastinum with alpha-fetoprotein production.

Authors:  Ken Takezawa; Isamu Okamoto; Junya Fukuoka; Kaoru Tanaka; Hiroyasu Kaneda; Hisao Uejima; Hyung-Eun Yoon; Masami Imakita; Masahiro Fukuoka; Kazuhiko Nakagawa
Journal:  J Thorac Oncol       Date:  2008-02       Impact factor: 15.609

View more
  4 in total

1.  (18)F-FDG PET/CT Presentation in a Patient Diagnosed with Large Cell Neuroendocrine Carcinoma of Uncertain Primary.

Authors:  Federico Caobelli; Claudio Pizzocaro; Fausto Zorzi; Maurizio Migazzi; Ugo Paolo Guerra
Journal:  Nucl Med Mol Imaging       Date:  2012-12-14

2.  Primary atypical carcinoid tumor of the mediastinum: a very rare finding.

Authors:  Luigi Ventura; Letizia Gnetti; Enrico Maria Silini; Guido Rindi; Paolo Carbognani; Michele Rusca; Luca Ampollini
Journal:  J Thorac Dis       Date:  2017-04       Impact factor: 2.895

3.  Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case report.

Authors:  In Young Jo; Seung-Gu Yeo
Journal:  Onco Targets Ther       Date:  2019-02-18       Impact factor: 4.147

4.  Large Cell Neuroendocrine Carcinoma of the Mediastinum Successfully Treated with Systemic Chemotherapy after Palliative Radiotherapy.

Authors:  Takeaki Hidaka; Saki Okuzumi; Ako Matsuhashi; Hidenori Takahashi; Kazunori Hata; Seiichiro Shimizu; Yoshinobu Iwasaki
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.